Insiders / Bruns Ingmar
Bruns Ingmar
CIK 1838041personinsider
Companies
2
First seen
Jan 4, 2021
Last activity
Feb 10, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Zentalis Pharmaceuticals Inc · ZNTL | 33,332 | — |
| Trillium Therapeutics Inc. · TRIL | — | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Zentalis Pharmaceuticals Inc | Common stock | 33,332 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Zentalis Pharmaceuticals Inc | Options | 365,000 |
Other
| Company | Security | Shares |
|---|---|---|
| Zentalis Pharmaceuticals Inc | Unclassified | 36,629 |
| Zentalis Pharmaceuticals Inc | Unclassified | 16,629 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 6, 2025 | Buy Open-market buy | ZNTL Zentalis Pharmaceuticals Inc Common Stock | $45.7K | +20K +120.27% | 36,629 0.05% of shares | low |
| Feb 6, 2026 | Sell Open-market sale | ZNTL Zentalis Pharmaceuticals Inc Common Stock | $7.2K | -3K -8.09% | 33,667 0.05% of shares | low |
| Feb 9, 2026 | Sell Open-market sale | ZNTL Zentalis Pharmaceuticals Inc Common Stock |